Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide

Storey, Cappai·1999·Neuropathology and Applied Neurobiology

Abstract

Alzheimer’s disease is characterized by the accumulation of beta amyloid peptides in plaques and vessel walls and by the intraneuronal accumulation of paired helical filaments composed of hyperphosphorylated tau. In this review, we concentrate on the biology of amyloid precursor protein, and on the central role of amyloid in the pathogenesis of Alzheimer’s disease. Amyloid precursor protein (APP) is part of a super‐family of transmembrane and secreted proteins. It appears to have a number of roles, including regulation of haemostasis and mediation of neuroprotection. APP also has potentially important metal and heparin‐binding properties, and the current challenge is to synthesize all these varied activities into a coherent view of its function. Cleavage of amyloid precursor protein by β‐and γ‐secretases results in the generation of the Aβ (βA4) peptide, whereas α‐secretase cleaves within the Aβ sequence and prevents formation from APP. Recent findings indicate that the site of γ‐secretase cleavage is critical to the development of amyloid deposits; Aβ 1–42 is much more amyloidogenic than Aβ 1–40 . Aβ 1–42 formation is favoured by mutations in the two presenilin genes (PS1 and PS2), and by the commonest amyloid precursor protein mutations. Transgenic mouse models of Alzheimer’s disease incorporating various mutations in the presenilin gene now exist, and have shown amyloid accumulation and cognitive impairment. Neurofibrillary tangles have not been reproduced in these models, however. While aggregated Aβ is neurotoxic, perhaps via an oxidative mechanism, the relationship between such toxicity and neurofibrillary tangle formation remains a subject of ongoing research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2990.1999.00164.x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 169

Metadata

Authors
Storey, & Cappai
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
1999-04
Volume
25
Issue
2
Pages
81-97
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2041656692
Cited by
169
References
35
FWCI
6.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide. https://app.cochat.ai/papers/10.1046/j.1365-2990.1999.00164.x
The paper
Storey, & Cappai. (1999). The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide. Neuropathology and Applied Neurobiology. https://doi.org/10.1046/j.1365-2990.1999.00164.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.